Does this mean that COgstate didn't take part in this phase 3 Clarity AD study of Lecanemab?
"Cogstate was not party to the collaborative arrangement between Eisai and Biogen in respect of the confirmatory clinical study"
So if not Cogstate, who then?
Ann: Industry News, page-4
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.030(2.49%) |
Mkt cap ! $200.6M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.20 | $1.18 | $38.11K | 31.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 800 | 1 |
View Market Depth
| Last trade - 14.23pm 30/07/2024 (20 minute delay) ? |
| CGS (ASX) Chart |